JvWJohan van WeyenberghPhDSlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #28 SARS-CoV-2 Mpro Protease as a Biomarker and Therapeutic Target in Long COVID: A Real-World Prospective Cohort Study - Johan van WeyenberghView Slideset
SlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #29 Long COVID and Sleep in the Youngest Children: Evidence From the RECOVER-Pediatrics Study - Rakesh BhattacharjeeView Slideset
MSMelissa StockwellMD, MPHSlidesetLong COVIDCOVID-193rd Long COVID International Conference 2025Abstract #30 Preventive Effect of Vaccination on Long COVID in Adolescents with SARS-CoV-2 Infection: RECOVER Pediatric Cohort - Melissa StockwellView Slideset
SlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #31 Low Dose Naltrexone Therapy in Long COVID: Real-World Clinical Experience from a Large Long COVID Clinic - Emma TippettView Slideset
SlidesetLong COVIDCOVID-193rd Long COVID International Conference 2025Abstract #33 SARS-CoV-2-Specific Monoclonal Antibody Therapy May Be More Beneficial in People with Low Baseline Antibody Titers - Amelia DeitchmanView Slideset
HRHarrison ReederPhDSlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #32 Intrauterine Exposure to SARS-CoV-2 and Infant Neurodevelopment through 18 Months of Age: Findings from the RECOVER Pregnancy Study - Harrison ReederView Slideset
CBCarolyn BramanteMD MPHSlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #34 Metformin on the Presence of COVID-19 Symptoms 6 Months after Infection: The ACTIV-6 Randomized Clinical Trial - Carolyn BramanteView Slideset
SlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #35 Rivaroxaban, Colchicine and Famotidine-Loratadine with Specialist Clinical Care for Long COVID, A Multi-Site, Open-Label Randomised Controlled Trial - Emma WallView Slideset
SlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #36 A Randomized Controlled Trial of Nicotinamide Riboside in Individuals with Long-COVID - Edmarie Guzman-VelezView Slideset
AMCAngela M. CheungMD, PhD, FRCPC, CCD,SlidesetCOVID-19Long COVID3rd Long COVID International Conference 2025Abstract #37 Efficacy of Ibudilast for the Treatment of Post COVID-19 Condition – The RECLAIM (REcovering from COVID19 Lingering Symptoms Adaptive Integrative Medicine (RECLAIM)) Platform Trial (RECLAIM-IBU) - Angela CheungView Slideset
SlidesetHIV9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025Abstract #9 HIV-Related Knowledge, Attitudes, and Stigma Among Romanian Nurses - Oana InescuView Slideset
PKPavel KhaykinMDSlidesetHIVViral Hepatitis and Liver Disease9th Central and Eastern European Meeting on Viral Hepatitis and HIV 2025Closing Gaps: Migrants and People Who Inject Drugs - Pavel KhaykinView Slideset
